Showing results (331-340 of 346) with videos related to
Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancerA Weaver, J Chang, E Wrigley, et al.Frontiers in Immunology|March 19, 2020
GPU-Accelerated Discovery of Pathogen-Derived Molecular Mimics of a T-Cell Insulin EpitopeThomas Whalley, Garry Dolton, Paul E Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's LymphomaJ Lundin, A Osterborg, G Brittinger, et al.British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2014
Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRsKatie Tungatt, Valentina Bianchi, Michael D Crowther, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 9, 2011
Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly menA Ratkevicius, A Joyson, I Selmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's diseaseJ A Radford, A Z S Rohatiner, W D J Ryder, et al.The Journal of Biological Chemistry|December 2, 2016
Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse TranscriptaseDavid K Cole, Hugo A van den Berg, Angharad Lloyd, et al.Nature Immunology|March 4, 2020
Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1Michael D Crowther, Garry Dolton, Mateusz Legut, et al.Nature Immunology|January 22, 2020
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1Michael D Crowther, Garry Dolton, Mateusz Legut, et al.Pageof 35